CJC-1295
CJC-1295, in this catalog, is the name on a co-lyophilized research listing of modified GRF(1–29) without a drug-affinity complex plus ipamorelin, at https://onesourcepeptides.com/product/cjc-1295-no-dac-5mg-plus-ipamorelin-5mg.
Modified GRF(1–29) without DAC is discussed as a short analogue at the GHRH receptor. The "no DAC" wording means the listing is not the longer drug-affinity-complex form. The catalog does not sell that name as a single-peptide vial. The product path pairs it with Ipamorelin, a ghrelin-receptor peptide, usually marked 5 mg and 5 mg. The blend note is CJC-1295 no DAC + Ipamorelin.
Each parent peptide has its own papers. A controlled study of this exact co-lyophilized ratio was not identified for this note. The pair is a research formulation, not an approved combination.
This page does not discuss physique, aging, or performance. It names the signalling classes on the listing and points at the catalog page for laboratory supply. The lot certificate, not the short name, decides the sequences in the vial.